RIMON Therapeutics was co-founded in 2000 by Dr. Michael May and Prof. Michael Sefton. They recognized that advanced materials are increasingly in demand to guide the regeneration of tissue, replace function and deliver drugs. The development of advanced biomaterials is a critical driver of the next age of medical products.

Based in Toronto, Canada, RIMON Therapeutics aims to develop and market novel products in partnership with biotechnology, pharmaceutical and medical device companies.

RIMON Therapeutics is taking biomaterials science to a new level. The Company is developing synthetic polymers that are bioactive, that is they act like drugs but have the physical properties of materials. These advanced materials stimulate the body to heal itself.

Please click the Register button to gain access to this presentation. If you have already Registered for this presentation please enter your email and click the Login button.